Home Tablets & Capsules Diampa L XR 25/5/1000mg Tablet – Triple Action Type 2 Diabetes Control with Empagliflozin, Linagliptin & Metformin
Diampa LT 10mg+5mg Tablet – Dual Therapy with Empagliflozin 10mg & Linagliptin 5mg for Type 2 Diabetes Back to Tablets & Capsules Diampa 25mg Tablet (Empagliflozin) – Maximum Strength SGLT2 Inhibitor for Type 2 Diabetes
Diampa L XR 25/5/1000mg tablet

Diampa L XR 25/5/1000mg Tablet – Triple Action Type 2 Diabetes Control with Empagliflozin, Linagliptin & Metformin

  • Triple combo (Empagliflozin 25mg + Linagliptin 5mg + Metformin XR 1000mg)
  • Once-daily tablet with heart, kidney & weight benefits
In stock
9 People are viewing this right now
Sale price Rs.415.00 PKR
Add to Wishlist

Diampa L XR 25/5/1000mg tablet
Diampa L XR 25/5/1000mg Tablet – Triple Action Type 2 Diabetes Control with Empagliflozin, Linagliptin & Metformin
Sale priceRs.415.00 PKR
SKU:
Categories: Medicines Tablets & Capsules
Tags: Diabetes Combination Tablet SGLT2 + DPP4 + Metformin Triple Therapy
Diampa L XR 25/5/1000mg tablet

Diampa L XR 25/5/1000mg Tablet – Triple Action Type 2 Diabetes Control with Empagliflozin, Linagliptin & Metformin

Rs.415.00

Diampa L XR 25/5/1000mg Tablet – Complete Once-Daily Therapy for Superior Blood Sugar Management

Diampa L XR 25/5/1000mg Tablet combines three powerful anti-diabetic agents – Empagliflozin 25mg (SGLT2 inhibitor), Linagliptin 5mg (DPP-4 inhibitor), and Metformin XR 1000mg (biguanide) – in a single extended-release tablet. This triple combination works through complementary mechanisms to deliver robust HbA1c reduction, promote urinary glucose excretion, enhance insulin secretion, and improve insulin sensitivity. Ideal for patients with inadequate control on dual therapy, it offers added cardiovascular and kidney protection along with convenient once-daily dosing.

  • Powerful triple mechanism for superior HbA1c reduction
  • Proven cardiovascular and kidney protection from Empagliflozin 25mg
  • Convenient once-daily dosing improves patient adherence
  • Supports weight loss and better insulin sensitivity
  • Extended-release formula minimizes gastrointestinal side effects

  1. Take one Diampa L XR 25/5/1000mg tablet once daily with a meal, preferably in the evening
  2. Swallow the tablet whole with water – do not crush, chew, or break (extended-release)
  3. Continue your prescribed diet and exercise regimen
  4. Monitor blood glucose regularly as advised by your doctor
  5. Attend routine check-ups for kidney function, vitamin levels, and overall control

Q1: Why is Diampa L XR taken only once daily?
A1: The extended-release metformin plus long-acting Empagliflozin and Linagliptin allow effective 24-hour control with one tablet.

Q2: Can I cut or crush the tablet if it’s hard to swallow?
A2: No – crushing destroys the extended-release property and may cause side effects or reduced efficacy.

Q3: Will this combination cause low blood sugar (hypoglycemia)?
A3: Risk is low when used alone, but increases if combined with insulin or sulfonylureas.

Q4: Is weight loss expected with Diampa L XR?
A4: Yes, most patients experience modest weight loss due to the Empagliflozin component.

Q5: Does it protect heart and kidneys like plain Empagliflozin?
A5: Yes, the Empagliflozin 25mg in this triple combo provides the same proven cardio-renal benefits.

Empagliflozin, Linagliptin, Metformin Hydrochloride (Extended-Release), Microcrystalline Cellulose, Hypromellose, Magnesium Stearate, Colloidal Anhydrous Silica, Opadry Coating

  • Not suitable for type 1 diabetes or diabetic ketoacidosis
  • Risk of lactic acidosis with metformin – avoid excessive alcohol and inform doctor of kidney issues
  • Stay hydrated to prevent dehydration from Empagliflozin
  • Monitor for genital fungal infections or urinary tract infections
  • May cause vitamin B12 deficiency with long-term use – periodic checking recommended
  • Keep out of reach of children and store below 30°C in a dry place

You may also like

Recently viewed products